Pediapharm Inc. (Pediapharm) is a privately held Canada based specialty pharmaceutical company. It is engaged in providing pediatric specialty medicines. The various products offered by the company include epiceram to treat dry skin conditions and also to manage and relieve itching and burning associated with dermatoses, including atopic dermatitis. NYDA is for the treatment and eradication of head lice and suprax for the treatment of pharyngitis, tonsillitis, otitis media, sinusitis and acute bronchitis. Pediapharm has a network of 2,000 pediatricians and 5,000 pharmacies and is focusing to partner with healthcare entities such as Sanofi Aventis, Apr Applied Pharma, Ceragenix Pharma and Pohl Boskamp to bring the innovative products to the Canadian market. It has also entered into distribution and supply agreement for epiceram with Ceragenix pharmaceuticals, Inc, a medical device company. Its upcoming products are vapaolyptus patch (OTC) to clear the air passages in children with cold symptoms or allergies during bedtime and kool-effects patch (OTC) to reduce the symptoms of fever or headaches. Pediapharm is headquartered in Ile des SÃƒÆ’Ã¢â‚¬Â¦ÃƒÂ¢Ã¢â€šÂ¬Ã…â€œurs, Quebec, Canada.